Nov 15, 2017 ... Hartman v. Janssen Research & Development LLC et al (2:17-cv-12533), Louisiana Eastern District Court, Filed: 11/15/2017 - PacerMonitor Mobile Federal and Bankruptcy Court PACER Dockets.
Jan 5, 2018 ... Robert Marr, et al v. Janssen Research and Development LLC et al (2:18-cv- 00109), California Central District Court, Filed: 01/05/2018 - PacerMonitor Mobile Federal and Bankruptcy Court PACER Dockets.
Dec 1, 2016 ... ANZO v. JANSSEN RESEARCH & DEVELOPMENT, LLC, ET AL.,. C.A. No. 2:15! 02217. Northern District of Georgia. BRAZIL v. JANSSEN RESEARCH & DEVELOPMENT LLC, ET AL.,. C.A. No. 4:15!00204. Northern District of Illinois. DAVIS v. JANSSEN PHARMACEUTICALS, INC., C.A. No. 1:16!08838.
Oct 21, 2015 ... HARVESTERS ENTERPRISES, LLC v. BUMBLE BEE FOODS LLC, ET AL.,. C.A. No. 3:15!00628. MDL No. 2671 ! IN RE: QUEST INTEGRITY USA, LLC, ('874) PATENT LITIGATION. Motion of plaintiff Quest Integrity USA, LLC, to transfer the following actions to the. United States District Court for the District ...
Apr 1, 2015 ... The propensity score was estimated using Bayesian logistic regression software ( Genkin et al., 2007). The propensity .... Erica A. Voss, Patrick B. Ryan, Paul E. Stang, and David Hough are employees of Janssen Research & Development, LLC, and are Johnson & Johnson stockholders. Larry Alphs is an ...
Dec 9, 2014 ... 2008; Woolley et al. 2008). Treatment with mGlu2/3 receptor agonists may also have potential limitations in terms of tolerance development (Galici et al. ... ( Sunnyvale, CA); [3H]JNJ-40068782, [3H]JNJ-46281222, and [3H]MDL-100907 were synthesized at Janssen Research and Development (Beerse, ...
May 20, 2014 ... Early in vitro experimental data have shown that orexin A increased glutamate release from hypothalamic slices (van den Pol et al., 1998). ... GSK-1059865 was synthetized at Janssen Research and Development LLC and was formulated in 30% sulfobutylether(7)-β-cyclodextrin (SBE) or 5% Pharmasolve, ...